The iTClamp is a wound closure device to manage difficult-to-control bleeding of a penetrating injury. It clamps the skin edges of a wound closed to create a temporary pool of blood under pressure, which stops further blood loss. The iTClamp has demonstrated that it can be deployed in a few seconds and stop serious bleeding from wounds in compressible areas of the body quickly and reliably.
With an addressable market at launch of ~$1.4 billion, major market segments for the iTClamp include First Responders, Military, and Hospital Emergency Departments. The iTClamp currently has first mover’s advantage to capture a significant market percentage of tens of millions of uses. iTraumaCare has launched the iTClamp into the US, Canada, Europe and selected markets in the Middle East. The Company has trained and supports an experienced network of distributors in these markets. No comparable product exists in the point-of-injury space.